Matching articles for "PrecivityAD"
Drugs for Dementia
The Medical Letter on Drugs and Therapeutics • March 30, 2026; (Issue 1751)
Alzheimer's disease (AD) is the most common cause
of dementia, but cognitive decline also occurs in
other neurological conditions, such as Parkinson's
disease, Lewy body dementia, vascular dementia,...
Alzheimer's disease (AD) is the most common cause
of dementia, but cognitive decline also occurs in
other neurological conditions, such as Parkinson's
disease, Lewy body dementia, vascular dementia, and
frontotemporal dementia.
AD-Detect — A Blood Test for Alzheimer's Disease
The Medical Letter on Drugs and Therapeutics • October 30, 2023; (Issue 1688)
AD-Detect (Quest), a blood test to evaluate
Alzheimer's disease risk, is being marketed directly
to consumers. It has not been cleared or approved
by the FDA (laboratory-developed tests like this
one...
AD-Detect (Quest), a blood test to evaluate
Alzheimer's disease risk, is being marketed directly
to consumers. It has not been cleared or approved
by the FDA (laboratory-developed tests like this
one currently do not need FDA authorization to be
marketed).